The neurologist at Banner-University Medicine Neuroscience Institute offered his perspective on data from an open-label safety assessment of cannabidiol (Epidiolex) in the treatment of tuberous sclerosis complex.
Steve Chung, MD
Advertisement
Articles by Steve Chung, MD
The neurologist at Banner-University Medicine Neuroscience Institute discussed the findings of a study that suggest perampanel may improve insomnia by decreasing anxiety in patients with epilepsy.
Advertisement
Latest Updated Articles
Steve Chung, MD: Perampanel's Effect on Insomnia in Patients With EpilepsyPublished: May 8th 2020 | Updated:
Steve Chung, MD: Cannabidiol in Tuberous Sclerosis ComplexPublished: May 13th 2020 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Early Results Show Symptom Gains in First Patient Dosed With UX-DA001 Cell Therapy for Parkinson Disease
2
Using Brain Stimulation to Curb Cannabis Overuse in Multiple Sclerosis
3
Testing D1 Receptor Modulator Glovadalen in Phase 2 Trial for Parkinson Disease: Milton Biagioni MD, CMD
4
Understanding Key Clinical and Genetic Biomarkers in Huntington Disease Research: Sarah O'Shea, MD, MSc
5
